AIM ImmunoTech Stock Target Price and Analyst Consensus

AIM Stock  USD 0.43  0.01  2.38%   
The current analyst and expert consensus on AIM ImmunoTech is Strong Buy, with only one strong buy opinion. The current projected AIM ImmunoTech target price consensus is 3.83 with 2 analyst opinions. The most common way AIM ImmunoTech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview AIM ImmunoTech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on AIM ImmunoTech. We encourage you to use your own analysis of AIM ImmunoTech to validate this buy or sell advice. AIM ImmunoTech buy-or-sell recommendation module provides average expert sentiment on the projected AIM ImmunoTech target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on AIM ImmunoTech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.
Lowest Forecast
3.49
Highest Forecast
4.25
Target Price
3.83
As of the 25th of April 2024, Gross Profit is likely to drop to about (81.9 K). In addition to that, Pretax Profit Margin is likely to grow to -136.21. At this time, AIM ImmunoTech's Common Stock Shares Outstanding is very stable compared to the past year. As of the 25th of April 2024, Liabilities And Stockholders Equity is likely to grow to about 29.4 M, while Other Current Liabilities is likely to drop about 1.3 M.
  
It's important to approach AIM ImmunoTech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize AIM ImmunoTech price targets

AIM ImmunoTech's stock target price is an estimate of its future price, usually made by analysts. Using AIM ImmunoTech's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at AIM ImmunoTech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if AIM ImmunoTech's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional AIM ImmunoTech Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of AIM ImmunoTech is a key component of AIM ImmunoTech valuation and have some predictive power on the future returns of a AIM ImmunoTech.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AIM ImmunoTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.446.54
Details
Intrinsic
Valuation
LowRealHigh
0.061.277.37
Details
Naive
Forecast
LowNextHigh
0.010.346.44
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.11-0.11-0.11
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AIM ImmunoTech. Your research has to be compared to or analyzed against AIM ImmunoTech's peers to derive any actionable benefits. When done correctly, AIM ImmunoTech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AIM ImmunoTech.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Banking Idea
Banking
Invested over 40 shares
When determining whether AIM ImmunoTech is a strong investment it is important to analyze AIM ImmunoTech's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AIM ImmunoTech's future performance. For an informed investment choice regarding AIM Stock, refer to the following important reports:
Check out Macroaxis Advice on AIM ImmunoTech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in AIM Stock, please use our How to Invest in AIM ImmunoTech guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for AIM Stock analysis

When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
The data published in AIM ImmunoTech's official financial statements usually reflect AIM ImmunoTech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AIM ImmunoTech. For example, before you start analyzing numbers published by AIM accountants, it's critical to develop an understanding of what AIM ImmunoTech's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of AIM ImmunoTech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AIM ImmunoTech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AIM ImmunoTech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AIM ImmunoTech. Please utilize our Beneish M Score to check the likelihood of AIM ImmunoTech's management manipulating its earnings.